Rankings
▼
Calendar
RAPT Q3 2023 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RAPT
RAPT Therapeutics, Inc.
$959M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$34M
Net Income
-$31M
EPS (Diluted)
$-6.54
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$200M
Total Liabilities
$27M
Stockholders' Equity
$173M
Cash & Equivalents
$54M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$34M
-$22M
-56.5%
Net Income
-$31M
-$21M
-47.7%
← FY 2023
All Quarters
Q4 2023 →